Accessibility Menu
Cannabist logo

Cannabist(OTC) CCHWF

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-100%
5 Year-100%
1 Year-100%
1 Month+0%
N/A
Cannabist last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-20
Cannabist stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-99.89%USD 0.002026-08-12
1 month+0%USD 0.002026-07-21
3 month-100%USD 0.032026-03-23
Year to date-100%USD 0.062025-12-31
1 year-100%USD 0.132025-08-20
3 year-100%USD 0.412023-08-21
5 year-100%USD 3.962021-08-20
Since inception-100%USD 7.202019-05-01

Cannabist Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$329.46M

Net Income (TTM)

-$40.57M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Nov 13, 2023

CCHWF News

person smiling and standing in a field of marijuana plants

1 Top Pot Stock Ready for a Bull Run

Jeffrey LittleMar 19, 2022
undertheradarcannabis

3 Cannabis Stocks You Can Buy and Hold for the Next Decade

James HalleyFeb 1, 2022
cannabis store

Is Columbia Care Stock a Buy Now?

Sushree MohantyJan 30, 2022
seedlings

Got $1,500? 3 Growth Stocks to Buy That Could Double Your Money

Sushree MohantyDec 14, 2021
A family reviewing financial results with an advisor.

Got $5,000? These 2 Beaten-Down Growth Stocks Are Great Buys for 2022

David Jagielski, CPANov 11, 2021
cannabis field

3 Leading Cannabis Stocks to Buy in 2021 and Beyond

Sushree MohantyNov 2, 2021
shiba inu dogecoin cryptocurrency getty

3 Cannabis Stocks That Are Better Buys Than Dogecoin

Rich DupreyOct 15, 2021
An advisor showing a tablet to a couple.

2 Slumping Growth Stocks to Buy Right Now

David Jagielski, CPASep 21, 2021
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cannabist

Columbia Care Inc. is a leading provider in the cannabis industry, specializing in the cultivation, production, and distribution of cannabis products. The company operates across 18 regions in the United States and the European Union, offering a diverse range of products through well-known brands.

Products and Services
  • Wide variety of cannabis products including flowers, edibles, oils, and tablets
  • Distribution through recognized brands such as Seed & Strain and Triple Seven
  • Operational footprint includes 131 locations with retail dispensaries and cultivation sites
Growth Outlook
  • Expansion into new markets is anticipated as cannabis legalization progresses
  • Increased consumer demand for cannabis products is expected to drive revenue growth
  • Strategic partnerships may enhance product offerings and market reach
Financial Highlights
  • Recent quarterly revenue of $79.9 million, showing resilience in a challenging market
  • Trailing twelve months (TTM) gross profit margin stands at 39.3%, indicating strong product demand
  • Operating cash flow has shown improvement, reflecting better management of working capital
Columbia Care Inc. has established itself as a significant player in the cannabis sector, with a comprehensive product lineup and a strategic approach to market expansion. The company's recent financial performance highlights its ability to generate substantial revenue, despite the challenges faced in the industry. With a focus on growth and innovation, Columbia Care is well-positioned to capitalize on the evolving cannabis landscape.
AI Generated • Aug 19, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

1,681

CEO

David James Hart, MBA

Website

www.cannabistcompany.com

Headquarters

New York City, NY 10019, US

CCHWF Financials

Key Financial Metrics (TTM)

Gross Margin

39.33%

Operating Margin

-81.36%

Net Income Margin

-81.32%

Return on Equity

-106.90%

Return on Capital

-11.20%

Return on Assets

-41.82%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$101.30M

Operating Income

-$31.08M

EBITDA

$14.30M

Operating Cash Flow

-$57.14M

Capital Expenditure

-$1.68M

Free Cash Flow

-$58.81M

Cash & ST Invst.

$17.76M

Total Debt

$144.39M

Cannabist Performance Analysis

Cannabist annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 460,080,000N/A
20222022-12-31USD 511,578,00011.2%
20232023-12-31USD 511,327,000-0.0%
20242024-12-31USD 458,722,000-10.3%
Cannabist sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-34.0%
Q12025-03-3115.4%
Q22025-06-30-1.2%
Q32025-09-30-7.5%
Cannabist annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.42N/A
20222022-12-31USD -1.06150.9%
20232023-12-31USD -0.44-58.8%
20242024-12-31USD -0.23-47.5%
Cannabist sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31150.0%
Q12025-03-31-131.6%
Q22025-06-30-140.5%
Q32025-09-3081.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$79.91M

-30.4%

Gross Profit

$22.91M

-47.7%

Gross Margin

28.67%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

2,505

N/A

Net Income

-$14.26M

-134.0%

EBITDA

$427.00K

-93.7%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

$17.76M

-43.6%

Total Debt

$144.39M

-69.8%

Accounts Receivable

$15.43M

+0.4%

Inventory

$66.83M

-25.5%

Long Term Debt

$132.90M

-67.9%

Short Term Debt

$11.49M

-82.1%

Return on Assets

-41.82%

N/A

Return on Invested Capital

-52.58%

N/A

Free Cash Flow

-$24.84M

+19.3%

Operating Cash Flow

-$24.59M

+15.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TRSSFTerrAscend Corp.
$1.72-11.79%
CLAZFClaritas Pharmaceuticals, Inc.
$0.00+0.00%
SSIISS Innovations International, Inc.
$3.59-0.69%
TBGNFOxurion N.V.
$0.17+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.10%
IBITiShares Bitcoin Trust
$43.68+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$10.41+0.06%
MARAMara Holdings
$11.26+0.01%

Questions About CCHWF

What is the current price of Cannabist?

Cannabist is trading at N/A per share.

What is the 52-week range for Cannabist?

Over the past 52 weeks, Cannabist has traded between N/A and N/A.

How much debt does Cannabist have?

As of the most recent reporting period, Cannabist reported total debt of $443.05M.

How much cash does Cannabist have on hand?

Cannabist reported $17.76M in cash and cash equivalents in its most recent financial results.

What is Cannabist’s dividend yield?

Cannabist does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services